Advancing the development of pan-sarbecovirus vaccines - Next steps
25 March 2022
| Meeting report

Overview
During this consultation (the second specifically addressing this topic) global experts reviewed the available evidence, enumerate knowledge gaps, and outlined research priorities related to pan-sarbecovirus vaccines. The objectives of the meeting were to:
- review scientific advances and development approaches to enable the development of a pan-sarbecovirus vaccine ;
- outline novel approaches for evaluation of pan-sarbecovirus vaccines, including in the context of the different variants of concern;
- discuss how we can prospectively evaluate vaccines intended to protect against viruses that are not yet circulating.
WHO Team
R&D Blue Print (RDB)
Number of pages
8